Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bioventus Inc BVS

Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products... see more

Recent & Breaking News (NDAQ:BVS)

BIOVENTUS SHAREHOLDER ACTION REMINDER

PR Newswire December 6, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bioventus Inc. - BVS

PR Newswire December 5, 2022

Bioventus Investor Alert

Newsfile December 1, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bioventus Inc. - BVS

Newsfile November 30, 2022

BVS BREAKING NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Bioventus Inc. Investors to Inquire About Securities Class Action Investigation - BVS

PR Newswire November 30, 2022

Bioventus Investor Alert

Newsfile November 29, 2022

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Bioventus Inc. (BVS) on Behalf of Investors

Business Wire November 29, 2022

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Bioventus Inc. (BVS) on Behalf of Investors

Business Wire November 29, 2022

The Law Offices of Frank R. Cruz Announces Investigation of Bioventus Inc. (BVS) on Behalf of Investors

Business Wire November 28, 2022

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Bioventus Inc. Investors to Inquire About Securities Class Action Investigation - BVS

Business Wire November 28, 2022

Bioventus Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Newsfile November 28, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bioventus Inc. - BVS

PR Newswire November 21, 2022

Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance

GlobeNewswire November 21, 2022

Bioventus Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Newsfile November 21, 2022

Bioventus Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Newsfile November 18, 2022

Bioventus Files for Extension to File Form 10-Q for the Period Ended October 1, 2022

GlobeNewswire November 16, 2022

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Bioventus Inc. and Encourages Investors with Losses to Contact the Firm

Newsfile November 14, 2022

INVESTIGATION NOTICE: The Schall Law Firm Announces It Is Investigating Claims Against Bioventus Inc. and Encourages Investors with Losses to Contact the Firm

Newsfile November 11, 2022

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Bioventus Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire November 9, 2022

Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance

GlobeNewswire November 8, 2022